Morgan Stanley »

Aspire Biopharma Holdings shares owned by Morgan Stanley

Quarter-by-quarter ownership of Aspire Biopharma Holdings shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Aspire Biopharma Holdings

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Holdings held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Holdings by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2026-03-31 $79k 77k 1.03

More positions owned by Morgan Stanley

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)

View all positions for Morgan Stanley

Top funds holding Aspire Biopharma Holdings

UBS Group
Morgan Stanley
Geode Capital Management
Crewe Advisors
Vanguard Capital Management
Toronto-Dominion Bank
Vanguard Fiduciary Trust
Citigroup
Efficient Wealth Management
SBI Securities
Caitong International Asset Management

View all funds holding Aspire Biopharma Holdings